FDA Inspection 967762 — Nephros, Inc.
The FDA completed an inspection of Nephros, Inc. on February 22, 2016 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 22, 2016
- Fiscal Year
- 2016
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Whippany, NJ (United States)